Search research articles
Contact Us
Filters
Showing results (641-650 of 886) with videos related to
Page
of 89
Sort By:
Scientific Reports
|
March 28, 2013
Imaging the action of antimicrobial peptides on living bacterial cells
Michelle L Gee, Matthew Burton, Alistair Grevis-James, et al.
European Journal of Pharmacology
|
December 5, 2002
Structural requirements for the interaction of sheep insulin-like factor 3 with relaxin receptors in rat atria
Yean Yeow Tan, Nicola F Dawson, Andrew R Kompa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 2011
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
Laszlo Otvos, Ilona Kovalszky, Mirko Riolfi, et al.
Human Molecular Genetics
|
April 30, 2008
Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway
Elisabeth A Lasater, Waylan K Bessler, Laura E Mead, et al.
The Journal of Biological Chemistry
|
July 13, 2002
INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent
Jin Kumagai, Sheau Yu Hsu, Hirotaka Matsumi, et al.
Blood
|
May 24, 2003
Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
Xiaxin Li, P Artur Plett, Yanzhu Yang, et al.
Biopolymers
|
June 22, 2010
Intramuscularly administered peptide A3-APO is effective against carbapenem-resistant Acinetobacter baumannii in mouse models of systemic infections
Eszter Ostorhazi, Ferenc Rozgonyi, Dora Szabo, et al.
Biopolymers
|
June 19, 2010
Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor
Fazel Shabanpoor, Suode Zhang, Richard A Hughes, et al.
The Journal of Biological Chemistry
|
June 26, 2008
Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist
Linda M Haugaard-Jönsson, Mohammed Akhter Hossain, Norelle L Daly, et al.
Cancers
|
June 26, 2025
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model
Pei-Yu Hung, Jessica A Moerland, Ana S Leal, et al.
Page
of 89
Search research articles
Search
Showing results (641-650 of 886) with videos related to
Sort By:
Page
of 89
Scientific Reports
|
March 28, 2013
Imaging the action of antimicrobial peptides on living bacterial cells
Michelle L Gee, Matthew Burton, Alistair Grevis-James, et al.
European Journal of Pharmacology
|
December 5, 2002
Structural requirements for the interaction of sheep insulin-like factor 3 with relaxin receptors in rat atria
Yean Yeow Tan, Nicola F Dawson, Andrew R Kompa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 2011
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
Laszlo Otvos, Ilona Kovalszky, Mirko Riolfi, et al.
Human Molecular Genetics
|
April 30, 2008
Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway
Elisabeth A Lasater, Waylan K Bessler, Laura E Mead, et al.
The Journal of Biological Chemistry
|
July 13, 2002
INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent
Jin Kumagai, Sheau Yu Hsu, Hirotaka Matsumi, et al.
Blood
|
May 24, 2003
Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
Xiaxin Li, P Artur Plett, Yanzhu Yang, et al.
Biopolymers
|
June 22, 2010
Intramuscularly administered peptide A3-APO is effective against carbapenem-resistant Acinetobacter baumannii in mouse models of systemic infections
Eszter Ostorhazi, Ferenc Rozgonyi, Dora Szabo, et al.
Biopolymers
|
June 19, 2010
Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor
Fazel Shabanpoor, Suode Zhang, Richard A Hughes, et al.
The Journal of Biological Chemistry
|
June 26, 2008
Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist
Linda M Haugaard-Jönsson, Mohammed Akhter Hossain, Norelle L Daly, et al.
Cancers
|
June 26, 2025
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model
Pei-Yu Hung, Jessica A Moerland, Ana S Leal, et al.
Page
of 89